INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that UroGen Pharma Ltd. (URGN) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, all dates inclusive (the 'Class Period'), have until July 28, 2025 to seek appointment as lead plaintiff of the UroGen class action lawsuit. Captioned Cockrell v. UroGen Pharma Ltd., 25-cv-06088 (D.N.J.), the UroGen class action lawsuit charges UroGen as well as certain of UroGen's top current and former executives with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the UroGen class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-urogen-pharma-ltd-class-action-lawsuit-urgn.html
You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].
CASE ALLEGATIONS: UroGen engages in the development and commercialization of solutions for specialty cancers. According to the complaint, UroGen's lead pipeline product is UGN-102 (mitomycin), an intravesical solution intended to treat low-grade intermediate risk non-muscle invasive bladder cancer.
The UroGen class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) UroGen's ENVISION clinical study for UGN-102 was not designed to demonstrate substantial evidence of effectiveness of UGN-102 because it lacked a concurrent control arm; (ii) as a result, UroGen would have difficulty demonstrating that the duration of response endpoint was attributable to UGN-102; (iii) UroGen failed to heed the U.S. Food and Drug Administration's ('FDA') warnings about the study design used to support a new drug application ('NDA') for UGN-102; and (iv) as a result, there was a substantial risk that the NDA for UGN-102 would not be approved.
The UroGen class action lawsuit further alleges that on May 16, 2025, the FDA published a briefing document in advance of its Oncologic Drugs Advisory Committee meeting regarding UroGen's NDA for UGN-102, which stated that '[g]iven that ENVISION lacked a concurrent control arm, the primary endpoints of complete response (CR) and duration of response (DOR) are difficult to interpret,' and that the FDA had 'recommended a randomized trial design to the Applicant several times during their product's development due to concerns with interpreting efficacy results' but UroGen 'chose not to conduct a randomized trial with a design and endpoints that the FDA considered appropriate.' On this news, the price of UroGen stock fell nearly 26%, according to the complaint.
Then, on May 21, 2025, the UroGen class action lawsuit further alleges that the Oncologic Drugs Advisory Committee voted against approving the UGN-102 NDA, finding that the overall benefit-risk of the investigation therapy UGN-102 is not favorable in patients with recurrent low-grade, intermediate-risk non-muscle invasive bladder cancer. On this news, the price of UroGen stock fell nearly 45%, according to the complaint.
THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired UroGen securities during the Class Period to seek appointment as lead plaintiff in the UroGen class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the UroGen class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the UroGen class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the UroGen class action lawsuit.
ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
https://www.rgrdlaw.com/services-litigation-securities-fraud.html
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Contact:
Robbins Geller Rudman & Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
[email protected]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Should You Buy Gold After Its 60% Increase in Value? Here's What Warren Buffett Has to Say About It.
The value of gold has soared more than 60% since the start of 2024, outpacing the S&P 500. With a weakening dollar and shaky political environment, gold still looks appealing at this price. Buffett and Munger suggest an even better asset for capital preservation. 10 stocks we like better than Berkshire Hathaway › The value of gold has increased faster than both stocks and bonds since the start of 2024 as growing uncertainty has led investors to seek safe havens. Despite the strong performance of the asset, many still feel it could be a great investment today, considering the world's political environment looks just as shaky as ever. But if you ask Warren Buffett if you should invest in gold, the answer is a clear and resounding "No." Analysts at J.P. Morgan disagree. Despite gold climbing about 60% in the last 18 months, they see the precious metal rising another 25% in value through the end of 2026, reaching $4,250 per ounce. But over the long run, there are some very good reasons why the asset will likely underperform stocks. Here's what Buffett thinks about gold, and how long-term investors can easily outperform it. The investment case for gold is that it's a hedge against inflation. If the dollar declines in value (as it has in recent months) the value of gold will increase relative to the dollar. That's because gold is rare. While gold mining companies are constantly digging it out of the ground, the process isn't cheap or easy. Buffett suggests there are much better ways to maintain the value of your dollars. "Gold would be way down on my list as a store of value," he told investors at Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) 2005 annual shareholder meeting. "I would much prefer owning a hundred acres of land here in Nebraska, or an apartment house, or an index fund." Charlie Munger, Berkshire Hathaway's longtime vice chairman and Buffett's friend, was much more blunt. "Gold is a dumb investment," he told the audience. Both of their points were that there are better opportunities, specifically assets that they would call "productive." That is, they have some level of utility beyond looking shiny, being highly conductive, and never corroding (which can be great for jewelry and electronics, but not much else). An ounce of gold will still be an ounce of gold in 100 years. An acre of farmland will still be an acre of land in 100 years. The difference, Buffett says, is that you got to use the land to grow crops and generate income during those 100 years while your ounce of gold probably just sat in a safe somewhere. A good business, like a farm, can protect against inflation because the value of what it produces won't change substantially. As such, in times of inflation, the price of its produce will increase, and the value of the asset will increase as well. Better yet, if you take the income from the asset and reinvest it in expanding (buying more farmland, adding another apartment, finding a new business to start or invest in), you can grow your wealth dramatically. Berkshire Hathaway itself may be the ultimate example. When Buffett took over Berkshire Hathaway in 1965, gold was worth about $35 per ounce. It's increased nearly 100-fold in the 60 years since. Berkshire Hathaway, on the other hand, is up about 58,664-fold. Buffett's advice for average investors is straightforward and simple. The best investment for the average individual is an index fund like the Vanguard S&P 500 ETF (NYSEMKT: VOO). While Buffett points out examples like farmland or apartments, those investments require management to be truly productive. He personally prefers to invest in individual companies. But those require attention as well, even if every publicly traded company has a board of directors and management in place already. If you want returns better than the market average, you'll have to do a lot of work. Even then, the best and brightest minds on Wall Street still struggle most of the time. So, for most people, a passive investment style where you simply buy and hold an index fund works best. A person who consistently adds money saved from their earnings to an index fund portfolio that produces average returns can end up with a level of wealth that's well above average. There's no need to diversify with other asset classes for long-term investors who can weather the ups and downs of the stock market. Even if you agree with J.P. Morgan's analysts that gold will continue to run higher through the end of next year, it's highly unlikely an unproductive asset outperforms a portfolio of productive assets over the long run. Those looking to tame the volatility of stocks may do better with government bonds. Buffett certainly thinks it's a better place to park cash than gold while he looks for Berkshire's next big stock purchase. Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 JPMorgan Chase is an advertising partner of Motley Fool Money. Adam Levy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway, JPMorgan Chase, and Vanguard S&P 500 ETF. The Motley Fool has a disclosure policy. Should You Buy Gold After Its 60% Increase in Value? Here's What Warren Buffett Has to Say About It. was originally published by The Motley Fool
Bloomberg
17 minutes ago
- Bloomberg
What's Next After the Initial Fallout from US Strikes on Iran
What's next? The unprecedented US airstrikes on Iran have set traders and governments worldwide on edge, as the Islamic Republic warns of retaliation and Israel shows no sign of letting up in its assault. Asian currencies and stocks fell, European stock futures declined while oil advanced, then erased gains, after Washington struck Iran's nuclear sites over the weekend. China and Pakistan were quick to condemn — even though China hasn't yet offered substantial assistance to Tehran besides rhetorical support and Pakistan is at the same time taking steps to build stronger ties with the White House. The US State Department issued a ' Worldwide Caution ' alert for Americans. More critically, President Donald Trump's decision to deploy bunker-busting bombs — in Washington's first direct military action against Iran after decades of hostility — has pushed the Middle East into uncharted territory. Did the end justify the means? While the US attacks have set back Iran's nuclear ambitions and dealt its clerical regime a humiliating blow, the program hasn't been completely destroyed. The move may ultimately lead Tehran to end international monitoring of its nuclear program and consider going ahead to develop a bomb. Supreme Leader Ayatollah Ali Khamenei hasn't been seen in public in 11 days but remains in control. Even as diplomatic allies Russia and China have stayed on the sidelines and its network of armed proxies in the region remains weakened, Tehran still has ways to inflict pain on the US as it plans its retaliation. Two supertankers, each capable of hauling about 2 million barrels of crude, U-turned in the Strait of Hormuz after the US airstrikes on Iran raised the risk of a response that would ensnare commercial shipping in the region, according to vessel tracking data compiled by Bloomberg. The two empty freighters then sailed south, away from the mouth of the Persian Gulf. The turning oil carriers offer the first signs of re-routing, something that oil traders will scrutinize. Any disruption to traffic through the strait, a major artery for global crude and natural gas, raises the specter of a spike in energy prices. That's bad news for Asia, which buys more than four-fifths of all the crude produced in the Middle East, 90% of which goes through the Strait of Hormuz.
Wall Street Journal
19 minutes ago
- Wall Street Journal
Stocks to Watch Monday: Exxon, Tesla, Northern Trust
↗️ Exxon (XOM), Chevron (CVX), BP (BP), Occidental Petroleum (OXY): Energy stocks gained modestly in premarket trading after the U.S. attacked Iranian nuclear facilities over the weekend. Investors are watching for signs Iran could block oil shipments through the Strait of Hormuz. ↘️ IAG (UK:IAG), Air France-KLM (FR:AF), Singapore Airlines (SG: C6L): Global airline stocks edged lower. Carriers including Air France cancelled some flights to the Middle East after the attack. U.S. airline stocks were little changed ahead of the open. ↗️ Tesla (TSLA): The electric-vehicle maker launched its long-awaited robotaxi service over the weekend. Shares rose 1.5% premarket.
